Mirae Asset Global Etfs Holdings Ltd. Charles River Laboratories International, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 4,173 shares of CRL stock, worth $563,271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,173
Previous 4,131
1.02%
Holding current value
$563,271
Previous $762,000
17.59%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
650Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$824 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$687 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$578 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$323 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$263 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.87B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...